David Rosenthal, DO, PhD, medical director at the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, reflects on a JAMA study, which states that use of antiretroviral therapy reduced the risk of HIV transmission during condomless sex.
Tanner White, a marine who has been diagnosed with HIV is making strides in fighting HIV-associated stigma by providing the public with education on the virus through the creation of his nonprofit organization called, “A Positive Tomorrow.”
Researchers at the Vanderbilt University School of Medicine have found that HIV-infected adults with depression are at a higher risk for cardiovascular disease and are more likely to experience heart attacks.
Researchers from the Copenhagen University Hospital of Denmark find that individuals who are hospitalized with infections have an increased risk of suicide ideation and death; individuals infected with hepatitis and HIV or AIDS have the highest risk of suicide-related death.
A new study finds that a balance of mutations, ones that impair the immune system’s ability to detect the HIV virus, and ones that impair the virus’s ability to replicate, will influence the speed of disease progression.
A UNC bioethicist is leading the PHASES Project, funded by a grant of over $3 million from the National Institutes of Health, in an effort to address the need for effective HIV prevention and treatment options for pregnant women worldwide.
An essential component of HIV that explains how the virus infects other cells and remains undetected by the immune system has been discovered by researchers at the MRC Laboratory of Molecular Biology in Cambridge and the University of London.
A new study conducted by researchers at John Hopkins Medicine has found that most of the proviruses in the latent HIV reservoir are defective but the current methods used to measure size of reservoirs, PCR and QVOA, are not precise in their measurements in that their results often count proviruses with and without defects.
Collateral damage from the ongoing opioid abuse epidemic in the United States continues to plague many rural communities across the country, with recent reports suggesting it is likely behind clusters of HIV cases in these areas.
Researchers have found that although HIV makes individuals more susceptible to acquire tuberculosis, it is not the cause of the spread of multidrug-resistant tuberculosis.
Although several ambitious initiatives intended to put an end to the AIDS epidemic have been developed and implemented, this laudable goal will be difficult to achieve without substantial and wide-scale changes in HIV prevention strategies.
Recently, there have been several breakthroughs in the fight against HIV, including trials that would test an HIV vaccine targeting a specific subtype of the virus, and several prevention methods that would reduce the risk of infection transmission.
Recent studies show that women are at higher risk of contracting HIV; however, measures can be taken to prevent infection, as well as the transmission of HIV from mother to child.
Groundbreaking research has uncovered several possibilities to potentially cure HIV in patients receiving antiretroviral therapy (ART), while a new drug prohibits the virus from maturing, preventing viral infection of new cells.
Since May, there have been nine confirmed cases, with one fatality, in Los Angeles, Long Beach, and Orange counties. According to the California Department of Public Health (CDPH), most of those infected have been gay and/or bisexual men.
The number of physicians and nurse practitioners aware of HIV pre-exposure prophylaxis (PrEP) and its potential benefits has increased dramatically in the years since it was first introduced to the market.
Researchers at McGill University in Montreal revealed that the gene editing tool known as CRISPR/Cas9, which had previously been shown to hold some promise in removing HIV-infected cells from the human genome, may in fact be a “double-edged sword.”
This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Incidence of syphilis is on the rise in Europe—particularly among men—according to a report released in May by the European Centre for Disease Prevention and Control (ECDC).
A recently published article in an Indian newspaper claims that thousands of civilians living across the country have contracted HIV through blood transfusions, in less than two years; however, a national AIDS organization is refuting these claims.
The Centers for Disease Control and Prevention (CDC) has released updated guidelines for the use of nonoccupational post-exposure prophylaxis (nPEP) in persons in the United States, after exposure to human immunodeficiency virus (HIV) outside the health care setting.
A recent study has demonstrated that, although annual HIV infection and transmission rates declined in the United States over the last 5 years, they fell short of the goals outlined in the US National HIV/AIDS Strategy.
A recent study has shown that human immunodeficiency virus (HIV) enters cells throughout the entire female reproductive tract from the labia to the ovary—not just in the cervix, as previously thought.
The results of a methylome-wide analysis of human immunodeficiency virus (HIV) chronically infected, combination anti-retroviral therapy (cART)-treated individuals recently published in Molecular Cell suggest that HIV+ individuals have an epigenetic age 4.9 years older than healthy controls, resulting in an expected total mortality risk increase of 19%.
In a one-arm study examined by the German Institute for Quality and Efficiency in Health Care (IQWiG), the added benefit of rilpivirine for HIV-positive children and adolescents between the ages of 12 and 18, was not proven, contrary to the belief of the manufacturer.
